Kausheyashma bhasma in epilepsy

AN OPEN LABEL SINGLE ARM PROSPECTIVE CLINICAL STUDY ON KOUSHEYASHMA BHASMA IN APASMARA (EPILEPSY)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013884

Enrollment

Registered

2018-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- EPILEPSY

Interventions

Intervention1: AN OPEN LABEL SIMGLE ARM PROSPECTIVE CLINICAL STUDY ON KOUSHEYASHMA BHASMA IN APASMARA(EPILEPSY): AN OPEN LABEL SIMGLE ARM PROSPECTIVE CLINICAL STUDY ON KOUSHEYASHMA BHASMA IN APASMARA(

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are not benefitted by taking epilepsy medicines without disturbing the antiepileptic medications. 17 to 60 years of age irrespective of gender and socio-economic status. Who follow the instructions and sign the informed consent. Patient who has more than one year history of Apasmara.

Exclusion criteria

Exclusion criteria: Subjects with uncontrolled diabetes mellitus and hypertension, congenital abnormalities Mental retardation, infectious diseases of brain, renal and hepatic impairment,vascular causes, substance abuse and metabolic causes of seizures Space occupying lesion. Pregnant woman. Lactating woman.

Design outcomes

Primary

Measure	Time frame
decrese in duration severity frequency of seizure,Timepoint: during treatment after 15 days after treatment after 15 days	—

Secondary

Measure	Time frame
ALLCAUSE MORTALITYTimepoint: ALLCAUSE MORTALITY	—

Countries

India

Contacts

Public ContactSUHAS KUMAR SHETTY

SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL BM ROAD THANNIRUHALLA HASSAN

drsuhasshetty@gmail.com9449603234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026